Neograft Technologies

company

About

Neograft Technologies focuses on developing cardiac technologies for use the heart bypass procedures.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$11M
Industries
Health Care,Health Diagnostics,Manufacturing,Medical
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

Neograft Technologies focuses on developing cardiac technologies for use in heart bypass procedures. The company's products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts.

It was founded in 2009 and headquartered in Taunton, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$11M
Neograft Technologies has raised a total of $11M in funding over 2 rounds. Their latest funding was raised on Jul 16, 2014 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 16, 2014 Series Unknown $11M 1 MAG Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Neograft Technologies is funded by 1 investors. MAG Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
MAG Ventures Yes Series Unknown